The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Decongestant Market Research Report 2025
Synopsis
Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.
The global Decongestant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Decongestant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decongestant.
Report Scope
The Decongestant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decongestant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decongestant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
Segment by Type
Tablets
Capsules
Nasal Sprays
Segment by Application
Hospitals
Research & Academic Laboratories
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Decongestant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.
The global Decongestant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Decongestant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decongestant.
Report Scope
The Decongestant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decongestant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decongestant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
Segment by Type
Tablets
Capsules
Nasal Sprays
Segment by Application
Hospitals
Research & Academic Laboratories
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Decongestant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Decongestant Market Overview
1.1 Product Overview and Scope of Decongestant
1.2 Decongestant Segment by Type
1.2.1 Global Decongestant Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Nasal Sprays
1.3 Decongestant Segment by Application
1.3.1 Global Decongestant Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Research & Academic Laboratories
1.3.4 Clinic
1.3.5 Other
1.4 Global Decongestant Market Size Estimates and Forecasts
1.4.1 Global Decongestant Revenue 2019-2030
1.4.2 Global Decongestant Sales 2019-2030
1.4.3 Global Decongestant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Decongestant Market Competition by Manufacturers
2.1 Global Decongestant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Decongestant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Decongestant Average Price by Manufacturers (2019-2024)
2.4 Global Decongestant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Decongestant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Decongestant, Product Type & Application
2.7 Decongestant Market Competitive Situation and Trends
2.7.1 Decongestant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Decongestant Players Market Share by Revenue
2.7.3 Global Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Decongestant Retrospective Market Scenario by Region
3.1 Global Decongestant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Decongestant Global Decongestant Sales by Region: 2019-2030
3.2.1 Global Decongestant Sales by Region: 2019-2024
3.2.2 Global Decongestant Sales by Region: 2025-2030
3.3 Global Decongestant Global Decongestant Revenue by Region: 2019-2030
3.3.1 Global Decongestant Revenue by Region: 2019-2024
3.3.2 Global Decongestant Revenue by Region: 2025-2030
3.4 North America Decongestant Market Facts & Figures by Country
3.4.1 North America Decongestant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Decongestant Sales by Country (2019-2030)
3.4.3 North America Decongestant Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Decongestant Market Facts & Figures by Country
3.5.1 Europe Decongestant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Decongestant Sales by Country (2019-2030)
3.5.3 Europe Decongestant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Decongestant Market Facts & Figures by Country
3.6.1 Asia Pacific Decongestant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Decongestant Sales by Country (2019-2030)
3.6.3 Asia Pacific Decongestant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Decongestant Market Facts & Figures by Country
3.7.1 Latin America Decongestant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Decongestant Sales by Country (2019-2030)
3.7.3 Latin America Decongestant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Decongestant Market Facts & Figures by Country
3.8.1 Middle East and Africa Decongestant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Decongestant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Decongestant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Decongestant Sales by Type (2019-2030)
4.1.1 Global Decongestant Sales by Type (2019-2024)
4.1.2 Global Decongestant Sales by Type (2025-2030)
4.1.3 Global Decongestant Sales Market Share by Type (2019-2030)
4.2 Global Decongestant Revenue by Type (2019-2030)
4.2.1 Global Decongestant Revenue by Type (2019-2024)
4.2.2 Global Decongestant Revenue by Type (2025-2030)
4.2.3 Global Decongestant Revenue Market Share by Type (2019-2030)
4.3 Global Decongestant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Decongestant Sales by Application (2019-2030)
5.1.1 Global Decongestant Sales by Application (2019-2024)
5.1.2 Global Decongestant Sales by Application (2025-2030)
5.1.3 Global Decongestant Sales Market Share by Application (2019-2030)
5.2 Global Decongestant Revenue by Application (2019-2030)
5.2.1 Global Decongestant Revenue by Application (2019-2024)
5.2.2 Global Decongestant Revenue by Application (2025-2030)
5.2.3 Global Decongestant Revenue Market Share by Application (2019-2030)
5.3 Global Decongestant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan N.V.
6.1.1 Mylan N.V. Corporation Information
6.1.2 Mylan N.V. Description and Business Overview
6.1.3 Mylan N.V. Decongestant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan N.V. Decongestant Product Portfolio
6.1.5 Mylan N.V. Recent Developments/Updates
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.2.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio
6.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.3 Ranbaxy Laboratories Ltd.
6.3.1 Ranbaxy Laboratories Ltd. Corporation Information
6.3.2 Ranbaxy Laboratories Ltd. Description and Business Overview
6.3.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ranbaxy Laboratories Ltd. Decongestant Product Portfolio
6.3.5 Ranbaxy Laboratories Ltd. Recent Developments/Updates
6.4 Beximco Pharmaceuticals Ltd.
6.4.1 Beximco Pharmaceuticals Ltd. Corporation Information
6.4.2 Beximco Pharmaceuticals Ltd. Description and Business Overview
6.4.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio
6.4.5 Beximco Pharmaceuticals Ltd. Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Decongestant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis AG Decongestant Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Cipla Ltd.
6.6.1 Cipla Ltd. Corporation Information
6.6.2 Cipla Ltd. Description and Business Overview
6.6.3 Cipla Ltd. Decongestant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Ltd. Decongestant Product Portfolio
6.6.5 Cipla Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Decongestant Industry Chain Analysis
7.2 Decongestant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Decongestant Production Mode & Process
7.4 Decongestant Sales and Marketing
7.4.1 Decongestant Sales Channels
7.4.2 Decongestant Distributors
7.5 Decongestant Customers
8 Decongestant Market Dynamics
8.1 Decongestant Industry Trends
8.2 Decongestant Market Drivers
8.3 Decongestant Market Challenges
8.4 Decongestant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Decongestant Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Decongestant Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Decongestant Market Competitive Situation by Manufacturers in 2023
Table 4. Global Decongestant Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Decongestant Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Decongestant Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Decongestant Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Decongestant Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Decongestant, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Decongestant, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Decongestant, Product Type & Application
Table 12. Global Key Manufacturers of Decongestant, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Decongestant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decongestant as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Decongestant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Decongestant Sales by Region (2019-2024) & (K Units)
Table 18. Global Decongestant Sales Market Share by Region (2019-2024)
Table 19. Global Decongestant Sales by Region (2025-2030) & (K Units)
Table 20. Global Decongestant Sales Market Share by Region (2025-2030)
Table 21. Global Decongestant Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Decongestant Revenue Market Share by Region (2019-2024)
Table 23. Global Decongestant Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Decongestant Revenue Market Share by Region (2025-2030)
Table 25. North America Decongestant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Decongestant Sales by Country (2019-2024) & (K Units)
Table 27. North America Decongestant Sales by Country (2025-2030) & (K Units)
Table 28. North America Decongestant Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Decongestant Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Decongestant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Decongestant Sales by Country (2019-2024) & (K Units)
Table 32. Europe Decongestant Sales by Country (2025-2030) & (K Units)
Table 33. Europe Decongestant Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Decongestant Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Decongestant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Decongestant Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Decongestant Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Decongestant Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Decongestant Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Decongestant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Decongestant Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Decongestant Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Decongestant Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Decongestant Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Decongestant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Decongestant Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Decongestant Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Decongestant Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Decongestant Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Decongestant Sales (K Units) by Type (2019-2024)
Table 51. Global Decongestant Sales (K Units) by Type (2025-2030)
Table 52. Global Decongestant Sales Market Share by Type (2019-2024)
Table 53. Global Decongestant Sales Market Share by Type (2025-2030)
Table 54. Global Decongestant Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Decongestant Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Decongestant Revenue Market Share by Type (2019-2024)
Table 57. Global Decongestant Revenue Market Share by Type (2025-2030)
Table 58. Global Decongestant Price (USD/Unit) by Type (2019-2024)
Table 59. Global Decongestant Price (USD/Unit) by Type (2025-2030)
Table 60. Global Decongestant Sales (K Units) by Application (2019-2024)
Table 61. Global Decongestant Sales (K Units) by Application (2025-2030)
Table 62. Global Decongestant Sales Market Share by Application (2019-2024)
Table 63. Global Decongestant Sales Market Share by Application (2025-2030)
Table 64. Global Decongestant Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Decongestant Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Decongestant Revenue Market Share by Application (2019-2024)
Table 67. Global Decongestant Revenue Market Share by Application (2025-2030)
Table 68. Global Decongestant Price (USD/Unit) by Application (2019-2024)
Table 69. Global Decongestant Price (USD/Unit) by Application (2025-2030)
Table 70. Mylan N.V. Corporation Information
Table 71. Mylan N.V. Description and Business Overview
Table 72. Mylan N.V. Decongestant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Mylan N.V. Decongestant Product
Table 74. Mylan N.V. Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 76. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 77. Teva Pharmaceutical Industries Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceutical Industries Ltd. Decongestant Product
Table 79. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 80. Ranbaxy Laboratories Ltd. Corporation Information
Table 81. Ranbaxy Laboratories Ltd. Description and Business Overview
Table 82. Ranbaxy Laboratories Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Ranbaxy Laboratories Ltd. Decongestant Product
Table 84. Ranbaxy Laboratories Ltd. Recent Developments/Updates
Table 85. Beximco Pharmaceuticals Ltd. Corporation Information
Table 86. Beximco Pharmaceuticals Ltd. Description and Business Overview
Table 87. Beximco Pharmaceuticals Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Beximco Pharmaceuticals Ltd. Decongestant Product
Table 89. Beximco Pharmaceuticals Ltd. Recent Developments/Updates
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Decongestant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Novartis AG Decongestant Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Cipla Ltd. Corporation Information
Table 96. Cipla Ltd. Description and Business Overview
Table 97. Cipla Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Cipla Ltd. Decongestant Product
Table 99. Cipla Ltd. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Decongestant Distributors List
Table 103. Decongestant Customers List
Table 104. Decongestant Market Trends
Table 105. Decongestant Market Drivers
Table 106. Decongestant Market Challenges
Table 107. Decongestant Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Decongestant
Figure 2. Global Decongestant Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Decongestant Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Nasal Sprays Product Picture
Figure 7. Global Decongestant Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Decongestant Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Research & Academic Laboratories
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Decongestant Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Decongestant Market Size (2019-2030) & (US$ Million)
Figure 15. Global Decongestant Sales (2019-2030) & (K Units)
Figure 16. Global Decongestant Average Price (USD/Unit) & (2019-2030)
Figure 17. Decongestant Report Years Considered
Figure 18. Decongestant Sales Share by Manufacturers in 2023
Figure 19. Global Decongestant Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Decongestant Players: Market Share by Revenue in 2023
Figure 21. Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Decongestant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Decongestant Sales Market Share by Country (2019-2030)
Figure 24. North America Decongestant Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Decongestant Sales Market Share by Country (2019-2030)
Figure 28. Europe Decongestant Revenue Market Share by Country (2019-2030)
Figure 29. Germany Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Decongestant Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Decongestant Revenue Market Share by Region (2019-2030)
Figure 36. China Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Decongestant Sales Market Share by Country (2019-2030)
Figure 47. Latin America Decongestant Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Decongestant Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Decongestant Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Decongestant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Decongestant by Type (2019-2030)
Figure 57. Global Revenue Market Share of Decongestant by Type (2019-2030)
Figure 58. Global Decongestant Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Decongestant by Application (2019-2030)
Figure 60. Global Revenue Market Share of Decongestant by Application (2019-2030)
Figure 61. Global Decongestant Price (USD/Unit) by Application (2019-2030)
Figure 62. Decongestant Value Chain
Figure 63. Decongestant Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
